Recombinant CEACAM5 (Tusamitamab Biosimilar) antibody

Catalog No. ABIN7538086

This anti-CEACAM5 (Tusamitamab Biosimilar) antibody is a Human Chimeric antibody detecting CEACAM5 (Tusamitamab Biosimilar) in ELISA and WB. Suitable for Human.

Quick Overview for Recombinant CEACAM5 (Tusamitamab Biosimilar) antibody (ABIN7538086)

Target: CEACAM5 (Tusamitamab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human, Mouse

Clonality: Chimeric

Conjugate: This CEACAM5 (Tusamitamab Biosimilar) antibody is un-conjugated

Application: ELISA, Western Blotting (WB)

Grade: Research Grade

Product Details anti-CEACAM5 (Tusamitamab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Tusamitamab Biosimilar - Anti-CEACAM5 mAb - Research Grade

Characteristics: Antibody Type: IgG1-kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Purity: > 85%

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS buffer PH7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for CEACAM5 (Tusamitamab Biosimilar)

Target: CEACAM5 (Tusamitamab Biosimilar)

Target Type: Biosimilar

Background: Tusamitamab is an IgG1 monoclonal antibody that targets CEACAM5. Tusamitamab can be used to synthesize Tusamitamab ravtansine, which is a first-in-class humanized antibody-drug conjugate (ADC) that combines Tusamitamab and DM4 (a potent maytansine derivative).

CAS-No: 2349294-95-5